On August 22, 2024 the FDA announced the approval plus EUA of the 2024-2025 formula of the Pfizer and Moderna mRNA COVID-19 vaccines, that “include a monovalent (single) component that corresponds to the Omicron variant KP.2 strain of SARS-CoV-2”. Novavax did not get an approval. [1, 2, 3]
New York Times reports many Americans, elderly and nursing home included, are NOT taking the booster shots, only 1/3 of nursing home residents are considered “up to date”.
“Vaccination continues to be the cornerstone of COVID-19 prevention,”
said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research.